Detalhe da pesquisa
1.
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation.
ESMO Open;
8(4): 101587, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356358
2.
Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer.
Ann Oncol;
32(12): 1597-1607, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487855
3.
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer.
Lung Cancer;
157: 21-29, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052705
4.
Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR-mutated non-small-cell lung cancer.
Curr Oncol;
27(6): 321-329, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380864
5.
Longitudinal health utilities, symptoms and toxicities in patients with ALK-rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment.
Curr Oncol;
27(6): e552-e559, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380870
6.
Diagnostic patterns of non-small-cell lung cancer at Princess Margaret Cancer Centre.
Curr Oncol;
27(5): 244-249, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173375
7.
Canadian consensus: a new systemic treatment algorithm for advanced EGFR-mutated non-small-cell lung cancer.
Curr Oncol;
27(2): e146-e155, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32489263
8.
A randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.
Curr Oncol;
27(2): e156-e162, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32489264
9.
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.
Curr Oncol;
26(4): e551-e557, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548824
10.
The economic impact of the transition from branded to generic oncology drugs.
Curr Oncol;
26(2): 89-93, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043808
11.
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials.
Eur J Cancer;
107: 1-7, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529898
12.
Afatinib in advanced pretreated non-small-cell lung cancer- a Canadian experience.
Curr Oncol;
25(5): e385-e390, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30464688
13.
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials.
Curr Oncol;
25(Suppl 1): S28-S37, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29910645
14.
Trends, practice patterns and underuse of surgery in the treatment of early stage small cell lung cancer.
Lung Cancer;
109: 117-123, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577940
15.
Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Lung Cancer;
109: 78-88, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577955
16.
Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.
Curr Oncol;
24(2): 103-110, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490924
17.
Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists.
Curr Oncol;
24(2): e138-e145, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490937
18.
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.
Ann Oncol;
28(4): 874-881, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168303
19.
Approach to biomarker testing: perspectives from various specialties.
Curr Oncol;
23(3): 178-83, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27330346
20.
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada.
Curr Oncol;
23(Suppl 1): S7-S13, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26985151